The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics / Hugh Myrick en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 4 (Agosto) . - pp. 365-372 Título : The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics Tipo de documento: texto impreso Autores: Hugh Myrick, Autor ; Xingbao Li, Autor ; Patrick K. Randall, Autor Fecha de publicación: 2022 Artículo en la página: pp. 365-372 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Neuroimagen, Alcoholismo, Craving, Aripiprazol Resumen: Because the effects of alcohol and its environmental cues on brain dopamine have been implicated in the maintenance of heavy drinking, drugs that modify dopamine might be useful in reducing drinking or promoting abstinence. The goal of the current study was to use an established brain imaging paradigm to explore the effect of aripiprazole (final dose 15 mg over a 14-day period), a dopamine stabilizer medication, on alcohol cue-induced brain activation and drinking in alcoholics. Link: ./index.php?lvl=notice_display&id=29435 [artículo] The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics [texto impreso] / Hugh Myrick, Autor ; Xingbao Li, Autor ; Patrick K. Randall, Autor . - 2022 . - pp. 365-372. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 4 (Agosto) . - pp. 365-372 Palabras clave: Neuroimagen, Alcoholismo, Craving, Aripiprazol Resumen: Because the effects of alcohol and its environmental cues on brain dopamine have been implicated in the maintenance of heavy drinking, drugs that modify dopamine might be useful in reducing drinking or promoting abstinence. The goal of the current study was to use an established brain imaging paradigm to explore the effect of aripiprazole (final dose 15 mg over a 14-day period), a dopamine stabilizer medication, on alcohol cue-induced brain activation and drinking in alcoholics. Link: ./index.php?lvl=notice_display&id=29435

---

1 (1 - 1 / 1)